HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,400.00
+45.00 (1.91%)
Aug 12, 2026, 3:30 PM KST

HLB Therapeutics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17,13120,31117,93423,70945,82199,873
Short-Term Investments
2,2002,5009,5678,64418,101560
Trading Asset Securities
-23,18710,272-89.45134.25
Cash & Short-Term Investments
19,33145,99837,77332,35364,012100,567
Cash Growth
-34.85%21.78%16.75%-49.46%-36.35%249.37%
Accounts Receivable
12,81714,3068,6269,4977,9006,448
Other Receivables
159.11363.75165.82339.49625.471,442
Receivables
12,97614,6708,7929,8378,5278,874
Inventory
7,0277,2375,3735,3366,4552,345
Prepaid Expenses
412.74288.01274.38161.96151.72133.07
Other Current Assets
6,6736,3081,9132,138865.591,333
Total Current Assets
46,42074,50054,12549,82580,012113,253
Property, Plant & Equipment
8,4518,8579,53010,06815,7809,781
Long-Term Investments
66,59243,08961,80458,60820,3353,715
Goodwill
-5,3885,3885,3881,075382.08
Other Intangible Assets
103,1816,5325,3994,8964,2603,925
Long-Term Deferred Tax Assets
2,0072,007----
Long-Term Deferred Charges
-85,59278,28369,10063,47257,586
Other Long-Term Assets
2,7112,6905,2642,9102,7091,070
Total Assets
229,362228,655219,793200,795187,643189,711

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6,7825,3614,8178,1832,5171,272
Accrued Expenses
1,6211,9251,106902.21,5101,819
Short-Term Debt
20,01410,76817,5317,43651,55150,441
Current Portion of Long-Term Debt
----98-
Current Portion of Leases
1,7441,445450.97624.24297.68364.54
Current Income Taxes Payable
328.65806.4----
Other Current Liabilities
4,0485,9098,0009,6452,6552,820
Total Current Liabilities
34,53726,21431,90426,79158,62856,717
Long-Term Debt
15,93625,3595,1701,84048-
Long-Term Leases
2,6302,978200.58122.2136.74320.7
Pension & Post-Retirement Benefits
--454.67328.13520.442,440
Other Long-Term Liabilities
241.63240.42194.81194.81194.81194.81
Total Liabilities
53,34554,79237,92529,27659,52859,672

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
44,29042,19140,07037,01615,99215,668
Additional Paid-In Capital
85,75387,865136,440125,17697,290190,850
Retained Earnings
6,27810,597-30,176-4,862-1,916-90,644
Treasury Stock
-1,480-1,474-1,120-483.65-413.53-413.53
Comprehensive Income & Other
16,41011,07512,2503,6205,7543,219
Total Common Equity
151,251150,254157,465160,466116,708118,679
Minority Interest
24,76723,61024,40411,05311,40811,360
Shareholders' Equity
176,018173,863181,868171,519128,116130,039
Total Liabilities & Equity
229,362228,655219,793200,795187,643189,711

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
40,32340,55023,35310,02252,13151,126
Net Cash (Debt)
-20,9925,44814,42022,33011,88149,441
Net Cash Growth
--62.22%-35.42%87.95%-75.97%219.98%
Net Cash Per Share
-238.1461.84170.82273.07166.30767.17
Filing Date Shares Outstanding
88.1583.9683.7481.2636.1473.28
Total Common Shares Outstanding
88.1583.9687.9381.2672.2973.28
Working Capital
11,88348,28622,22123,03421,38456,536
Book Value Per Share
1715.741789.641790.841974.621614.491619.44
Tangible Book Value
48,069138,334146,678150,182111,372114,372
Tangible Book Value Per Share
545.281647.661668.161848.081540.681560.66
Land
-1,4394,4294,4295,9164,429
Buildings
-2,5065,3005,1508,4675,146
Machinery
-7,8297,7112,92710,2532,737
Construction In Progress
-16.25--263.3-